er logo points to home page Home page Search Glossary Search Links Database Sitemap Contact Expert Reviews in Molecular Medicine
Reprint version of article Features associated with the article       Register interest

Expert Reviews in Molecular Medicine: http://www.expertreviews.org/
Accession information: Vol. 8; Issue 7; 11 April 2006 Abstract
PDF

Current model for cellular intoxication by anthrax toxin

David J. Banks, Sabrina C. Ward and Kenneth A. Bradley

Author contact details

Figure 1. Current model for cellular intoxication by anthrax toxin. Cellular intoxication begins when protective antigen (PA) binds membrane-bound surface-exposed anthrax toxin receptor (ANTXR). PA is secreted by Bacillus anthracis as an 83 kDa monomer and is proteolytically processed either on the surface of host cells or in the serum (Refs 123, 124) to remove a 20 kDa fragment from the N-terminus. The remaining 63 kDa fragment then heptamerises and binds the catalytic moieties lethal factor (LF) and oedema factor (OF). Oligomerisation of PA induces clustering of ANTXRs, which drives relocalisation into lipid rafts, resulting in dynamin- and clathrin-dependent endocytosis and COP1-, ARAP3-, and ALIX-dependent trafficking of the toxin complex. The endosome becomes acidified, causing the pre-pore structure to insert into the membrane and thus form a pore. LF and OF are delivered to the cytosol through the pore and act on host targets. LF inactivates MKKs/MEKs, promotes IL-8 mRNA decay, and activates Nalp1b. Dashed lines indicate hypothetical or unknown interactions during intoxication. Abbreviations: ALIX, apoptosis-linked gene 2 (ALG-2)-interacting protein X; cAMP, cyclic AMP; ANTXR, anthrax toxin receptor; ARAP3, ankyrin repeat and plekstrin homology domains-containing protein 3; H+S, proton; IL-8, interleukin 8; MKK/MEK, kinase for MAPKs/ERKs (mitogen-activated protein kinases or extracellular-signal-regulated kinases); PA, protective antigen. Adapted from Ref. 44 (Copyright 2004), with permission from Elsevier.

References cited in Figure 1

44 Sanchez, A.M. and Bradley, K.A. (2004) Anthrax toxin: can a little be a good thing? Trends Microbiol 12, 143-145, PubMed

123 Ezzell, J.W., Jr. and Abshire, T.G. (1992) Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol 138, 543-549, PubMed

124 Panchal, R.G. et al. (2005) Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem 280, 10834-10839, PubMed

| home | search | glossary | links | sitemap | contact |

Expert Reviews in Molecular Medicine © Cambridge University Press ISSN 1462-3994 (Disclaimer and copyright)
Editorial Office: Centre for Applied Research in Educational Technologies (CARET), 1st Floor, 16 Mill Lane, Cambridge, CB2 1SB, UK. Tel: +44 (0)1223 765 375; Fax: +44(0)1223 765 505; E-mail: ermm@caret.cam.ac.uk